MDT

Medtronic plc

$101.59

-1.17%
SectorHealthcareIndustryMedical DevicesCountryIreland

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products.

Source: Yahoo Finance
AI summary

Price & performance

1M+11.9%
3M+13.6%
YTD+3.1%
1Y+9.6%
52-week range—
Beta0.36
Full chart and returns against a benchmark

Q-Score

81/ 100

Quality against peers; 50 is the peer median.

Growth59
Risk96
Performance60
Valuation63
Profitability77
Leverage60
Sentiment59
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$36.4B+8.4%
Net income$4.8B+3.0%
Net margin13.2%-0.7 pts
Historical fundamentals

Revenue exposure

50%of revenue from outside the US
Total Other Countries, Excluding United States and Ireland50%
United States50%
Ireland0%
Regions, segments, customers and suppliers

Valuation

MDTIndustryP/E24.8429.61P/S3.463.49EV/EBITDA16.0818.38P/B2.593.39PEG2.032.03
Dividend yield2.81%
Every valuation metric

Earnings

Nov 24next report, before the open
EPS estimate$1.33
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate